Effectiveness of Telehealth Program in Patients With Type 2 Diabetes

Type 2 Diabetes Clinical Trial

Official title:

Effectiveness of Telehealth Program in Patients With Type 2 Diabetes: Randomized Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05202470
• Other study ID #: Mugla Sitki Kocman
• Status: Completed
• Phase: N/A
• Start date: January 6, 2022
• Est. completion date: May 15, 2023

Study information

• Verified date: June 2023
• Source: Mugla Sitki Koçman University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Diabetes education is of great importance in the effective management of diabetes. Studies have shown that patients given diabetes education have positive developments in their ability to manage the disease and their attitudes towards the disease. The aim of the study is to compare the education given to individuals with Type 2 diabetes via mobile phone and the education given to individuals via brochures with conventional methods.

Description:

The use of telehealth technologies in the field of health is becoming more and more widespread. Telehealth has become one of the frequently used options in the follow-up process of chronic diseases such as diabetes, especially in recent years. Diabetes education is of great importance in the effective management of diabetes. Studies have shown that patients given diabetes education have positive developments in their ability to manage the disease and their attitudes towards the disease. The aim of the study is to compare the education given to individuals with Type 2 diabetes via mobile phone and the education given to individuals via brochures with conventional methods.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: May 15, 2023
• Est. primary completion date: May 10, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Having a diagnosis of type 2 diabetes mellitus for at least 6 months,

• Those between the ages of 18-65,

• Receiving oral antidiabetic and/or insulin therapy,

• Having a mobile phone capable of receiving and playing video messages,

• Does not have hearing, speech and psychiatric problems that prevent communication,

Exclusion Criteria:

• Individuals who do not volunteered to participate in the study

• Patients who have hearing, speech and psychiatric problems that prevent communication

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 2
• Type 2 Diabetes

Intervention

Other:
• TE
After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.
• CE
After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.

Locations

Country	Name	City	State
Turkey	Mugla Training and Research Hospital	Mugla

Sponsors (1)

Lead Sponsor	Collaborator
Mugla Sitki Koçman University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	International Survey of Physical Activity (IPAQ)	Physical activity assessment	4 weeks
Primary	Goal orientation in exercise measure (GOEM)	Measurement of goal orientation in exercise	4 weeks
Primary	Mini Nutritional Assessment	To evaluate the nutrition status of the patients	4 weeks
Primary	The Problem Areas in Diabetes Scale (PADS)	PADS evaluates comprehensive diabetes evaluation. A total score is ranged between 0 - 100. Patients scoring 40 or higher may be at the level of "emotional burnout" and warrant special attention.	4 weeks